15 Diagnostic ability of artificial intelligence using deep learning analysis of cyst fluid in differentiating malignant from benign pancreatic cystic lesions

16 Infectious complications in children with malignant bone tumors: a multicenter nationwide study

17 Infectious complications in children with malignant bone tumors: a multicenter nationwide study

18 Infectious complications in children with malignant bone tumors: a multicenter nationwide study

19 Giant Muscle Invasive Dermatofibroma Clinically Mimicking a Malignant Tumor

20 Unusual Case of Malignant Struma Ovarii and Cervical Thyroid Cancer Preceded by Ovarian Teratoma: Case Report and Review of the Literature

21 Primary Pulmonary Malignant Melanoma Found While Evaluating New Onset Cough: A Case Presentation and Literature Review

22 Overall survival in malignant glioma is significantly prolonged by neurosurgical delivery of etoposide and temozolomide from a thermo-responsive biodegradable paste

23 An investigation of CNN models for differentiating malignant from benign lesions using small pathologically proven datasets.

24 Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.

25 Application of simulation-based CYP26 SNP-environment barcodes for evaluating the occurrence of oral malignant disorders by odds ratio-based binary particle swarm optimization: A case-control study in the Taiwanese population.

26 Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort

27 Accuracy of CT and MRI to assess resection margins in primary malignant bone tumours having histology as the reference standard

28 Radiologic Considerations And Standardization Of Malignant Pleural Mesothelioma (MPM) Imaging Within Clinical Trials: Consensus Statement From The NCI Thoracic Malignancy Steering Committee - International Association For The Study Of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.

29 Malignant PRES and RCVS after brain surgery in the early postpartum period.

30 Electrosurgical and Laser Therapy Tools for the Management of Malignant Central Airway Obstructions.

31 Progress due to networking structures : Challenges for the Competence Network Malignant Lymphomas in the Era of Precision Medicine

32 [Potential of Using Vitamin D as an Adjuvant Treatment of Malignant Melanoma].

33 Home-Based yoga program for the patients suffering from malignant lymphoma during chemotherapy: A feasibility study

34 CCR5 genetic variants and epidemiological determinants for HPV infection and cervical premalignant lesions.

35 Diagnostic accuracy of different computer-aided diagnostic systems for malignant and benign thyroid nodules classification in ultrasound images: A systematic review and meta-analysis protocol

36 [Complex treatment of mandibular malignant tumors using a fixing device for prophylaxis of pathological fracture, the early postoperative prosthesis and rehabilitation].

37 Management of Malignant Pleural Effusions-What Is New.

38 Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma.

39 Combinatorial Discovery of Defined Substrates That Promote a Stem Cell State in Malignant Melanoma

40 A Review of Selected Factors of Salivary Gland Tumour Formation and Malignant Transformation

41 Second malignant neoplasms in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO).

42 Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model.

43 Evaluation of the photon dose calculation accuracy in radiation therapy of malignant pleural mesothelioma

44 Intra-operative cerebrospinal fluid sampling versus post-operative lumbar puncture for detection of leptomeningeal disease in malignant paediatric brain tumours.

45 Preimplantation genetic diagnosis for a single gene mutation for succinate dehydrogenase subunit B (the genetic basis for malignant paraganglioma) with successful pregnancy

46 Targeted brain delivery nanoparticles for malignant gliomas.

47 Malignant Leydig Cell Tumor in Elderly Complete Androgen Insensitivity Patient: A Case Report.

48 Cloud-based decision support system for the detection and classification of malignant cells in breast cancer using breast cytology images.

49 Successful Surgery Management of Giant Periorbital Malignant Schwannoma in a Low-Income Setting.

50 Diagnosis of Benign and Malignant Breast Lesions on DCE-MRI by Using Radiomics and Deep Learning With Consideration of Peritumor Tissue.

51 CT-based radiomics for prediction of histologic subtype and metastatic disease in primary malignant lung neoplasms.

52 A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma.

53 Surgical Management of Non-Malignant Esophageal Perforations: A Single-Center Analysis Over a 15-Year Period.

54 Revisiting Hemicraniectomy: Late Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Stroke and the Role of Infarct Growth Rate.

55 Corrigendum to “Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution” (Surgical Oncology (2019) 31 (8–13), (S0960740419301823), (10.1016/j.suronc.2019.08.006))

56 Enzyme activity in relation to cancer: The urinary $\beta$-glucuronidase activity of patients suffering from malignant disease

57 Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease.

58 Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study.

59 Erratum to: Different apoptotic effects of wogonin via induction of H2O2 generation and Ca2+ overload in malignant hepatoma and normal hepatic cells (Journal of Cellular Biochemistry, (2010), 111, 6, (1629-1641), 10.1002/jcb.22898)

60 ELEMENT TRIAL: Study protocol for a randomized controlled trial on endoscopic ultrasound-guided biliary drainage of first intent with a lumen-apposing metal stent vs. endoscopic retrograde cholangio-pancreatography in the management of malignant distal biliary obstruction

61 Identification of malignant early repolarization pattern by late QRS activity in high-resolution magnetocardiography.

62 Spatial distribution of malignant transformation in patients with low-grade glioma.

63 TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.

64 [Incidence of malignant mesothelioma (1980-1999) and asbestos exposure in 190 cases diagnosed among residents of the province of Brescia].

65 Malignant Otitis Externa is Associated with Diabetes: A Population-Based Case-Control Study.

66 Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.

67 Killing malignant melanoma cells with protoporphyrin IX-loaded polymersome-mediated photodynamic therapy and cold atmospheric plasma

68 Secondary Malignant Diseases Related to Radiotherapy: Scientific Letter

69 Clinical profile of non-malignant submandibular swellings in mmimsr institute of medical sciences.

70 Multiparametric quantitative and texture F-FDG PET/CT analysis for primary malignant tumour grade differentiation.

71 Prognostic factors in malignant pleural mesothelioma: A retrospective study of 60 Turkish patients

72 Assessment of the oral health seeking behavior of patients with premalignant lesions.

73 Palliative Care of Malignant Fibrous Histiocytoma of Spine with Cord Compression and Multiple Bone Metastases Treated by Multidisciplinary Therapy: Case Report.

74 Pilosebaceous Malignant Transformation of Dermoid Cyst in the Orbit.

75 Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders

76 Ultrasound Image-Based Diagnosis of Malignant Thyroid Nodule Using Artificial Intelligence.

77 Combined blood and pleural levels of mesothelin and osteopontin for the diagnosis of malignant pleural mesothelioma

78 Differential Diagnosis of Benign and Malignant Thyroid Nodules Using Deep Learning Radiomics of Thyroid Ultrasound Images.

79 Association of CD204 macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCT.

80 Malignant Findings in Candidates for Transcatheter Aortic Valve Implantation.

81 Opportunistic Screening of Oral Potentially Malignant Disorders: A Public Health Need for India.

82 Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.

83 Malignant fibrous histiocytoma - a case report

84 Malignant fibrous histiocytoma - a case report

85 An insight into crystallization test: A neoteric approach for screening premalignant and malignant lesions

86 An insight into crystallization test: A neoteric approach for screening premalignant and malignant lesions

87 Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms

88 Malignant fibrous histiocytoma presenting as cystic pancreatic mass

89 Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis

90 Correlation between Three-Dimensional Volume and Malignant Potential of Gastrointestinal Stromal Tumors (GISTs)

91 Malignant peripheral nerve sheath tumor of the parapharyngeal space arising from cervical sympathetic chain: A rare entity

92 Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer

93 An International Consensus Study of Neuroleptic Malignant Syndrome Diagnostic Criteria Using the Delphi Method

94 Salivary L-fucose as a biomarker for oral potentially malignant disorders and oral cancer

95 Biochemical analysis of cytokeratin fragment 21-1 concentration and expression of cytokeratin 19 in oral potentially malignant disorders

96 Serum and salivary sialic acid as a biomarker in oral potentially malignant disorders and oral cancer

97 Serum and salivary sialic acid as a biomarker in oral potentially malignant disorders and oral cancer

98 Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer

99 Biochemical analysis of cytokeratin fragment 21-1 concentration and expression of cytokeratin 19 in oral potentially malignant disorders

100 Malignant peripheral nerve sheath tumor of the parapharyngeal space arising from cervical sympathetic chain: A rare entity

101 Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited

Keyword Connections

Journals

Research Groups

Bibliographies